RxSight, Inc.(NasdaqGM:RXST) dropped from Russell 3000E Growth Index
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
47.72 USD | -4.14% |
|
-16.21% | +18.35% |
10/07 | Stifel Adjusts Price Target on RxSight to $70 From $75, Maintains Buy Rating | MT |
08/07 | Certain Restricted Stock Units of RxSight, Inc. are subject to a Lock-Up Agreement Ending on 8-JUL-2024. | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.35% | 186.02Cr | |
-5.31% | 18TCr | |
-5.38% | 10TCr | |
-6.04% | 6.62TCr | |
+16.45% | 4.54TCr | |
-8.08% | 4.54TCr | |
+8.38% | 4.38TCr | |
+12.06% | 2.9TCr | |
+17.98% | 2.56TCr | |
-8.28% | 2.35TCr |
- Stock Market
- Equities
- RXST Stock
- News RxSight, Inc.
- RxSight, Inc.(NasdaqGM: RXST) dropped from Russell 3000E Growth Index